{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T01:57:39Z","timestamp":1783562259761,"version":"3.55.0"},"reference-count":81,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2017,6,26]],"date-time":"2017-06-26T00:00:00Z","timestamp":1498435200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0179520","type":"journal-article","created":{"date-parts":[[2017,6,26]],"date-time":"2017-06-26T17:40:47Z","timestamp":1498498847000},"page":"e0179520","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":31,"title":["The economic burden of human papillomavirus-related precancers and cancers in Sweden"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0668-088X","authenticated-orcid":true,"given":"Ellinor","family":"\u00d6stensson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Silfverschi\u00f6ld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennart","family":"Greiff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Asciutto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Wennerberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Louise","family":"Lydryp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"H\u00e5kansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e4r","family":"Spar\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christer","family":"Borgfeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,6,26]]},"reference":[{"issue":"6 Suppl 1","key":"ref1","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/01.ogx.0000221010.82943.8c","article-title":"Human papillomavirus: the burden of infection","volume":"61","author":"D Wiley","year":"2006","journal-title":"Obstet Gynecol Surv"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"JM Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/sj.bjc.6600688","article-title":"Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis","volume":"88","author":"GM Clifford","year":"2003","journal-title":"Br J Cancer"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1136\/jcp.2003.007641","article-title":"Molecular biology of squamous cell carcinoma of the head and neck","volume":"59","author":"B Perez-Ordonez","year":"2006","journal-title":"J Clin Pathol"},{"key":"ref5","first-page":"598","article-title":"Management of anogenital warts (condylomata acuminata)","volume":"11","author":"G von Krogh","year":"2001","journal-title":"Eur J Dermatol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1086\/313914","article-title":"Incidence and prevalence of recurrent respiratory papillomatosis among children in Atlanta and Seattle","volume":"31","author":"LR Armstrong","year":"2000","journal-title":"Clin Infect Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/jcp.2008.063149","article-title":"Human papillomavirus prevalence and type distribution in penile carcinoma","volume":"62","author":"C Miralles-Guri","year":"2009","journal-title":"J Clin Pathol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.oraloncology.2008.05.023","article-title":"Oral cancer prevention and control\u2014the approach of the World Health Organization","volume":"45","author":"PE Petersen","year":"2009","journal-title":"Oral Oncol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/jnci\/djs491","article-title":"Annual Report to the Nation on the Status of Cancer, 1975\u20132009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels","volume":"105","author":"A Jemal","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1758-3284-2-15","article-title":"Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC)","volume":"2","author":"F Dayyani","year":"2010","journal-title":"Head Neck Oncol"},{"issue":"Suppl 1","key":"ref11","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1007\/s12105-012-0371-6","article-title":"The morphologic profile of HPV-related head and neck squamous carcinoma: implications for diagnosis, prognosis, and clinical management","volume":"6","author":"WH Westra","year":"2012","journal-title":"Head Neck Pathol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI28607","article-title":"Prophylactic human papillomavirus vaccines","volume":"116","author":"DR Lowy","year":"2006","journal-title":"J Clin Invest"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1056\/NEJMoa0909537","article-title":"Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males","volume":"364","author":"AR Giuliano","year":"2011","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(09)60691-7","article-title":"Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24\u201345 years: a randomised, double-blind trial","volume":"373","author":"N Mu\u00f1oz","year":"2009","journal-title":"Lancet"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.5858\/arpa.2014-0554-RA","article-title":"Epigenetic mechanisms of human papillomavirus-associated head and neck cancer","volume":"139","author":"NV Anayannis","year":"2015","journal-title":"Arch Pathol Lab Med"},{"issue":"12 Suppl","key":"ref16","first-page":"DS197","article-title":"Panel on cost-effectiveness in health and medicine","volume":"34","author":"M Gold","year":"1996","journal-title":"Med Care"},{"key":"ref17","article-title":"Health economics series no. 6","author":"DP Rice","year":"1996"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e0139062","DOI":"10.1371\/journal.pone.0139062","article-title":"Cost of preventing, managing, and treating human papillomavirus (HPV)-related diseases in Sweden before the introduction of quadrivalent HPV vaccination","volume":"10","author":"E \u00d6stensson","year":"2015","journal-title":"PLoS One"},{"key":"ref19","unstructured":"Institut Catala d&apos;Oncologia. HPV center. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.hpvcentre.net\/index.php\" xlink:type=\"simple\">http:\/\/www.hpvcentre.net\/index.php<\/ext-link>."},{"key":"ref20","unstructured":"International Agency for Reseaech on Cancer. IARC website. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.iarc.fr\" xlink:type=\"simple\">www.iarc.fr<\/ext-link>."},{"key":"ref21","doi-asserted-by":"crossref","first-page":"145.e1","DOI":"10.1016\/j.ajog.2011.03.056","article-title":"Genotyping of human papillomavirus in triaging of low-grade cervical cytology","volume":"205","author":"A S\u00f6derlund-Strand","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1038\/sj.bjc.6602648","article-title":"Type distribution, viral load and integration status of high-risk human papillomaviruses in pre-stages of cervical cancer (CIN)","volume":"92","author":"S Andersson","year":"2005","journal-title":"Br J Cancer"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.3109\/0284186X.2011.584556","article-title":"Prevalence of human papillomavirus (HPV) types in cervical cancer 2003\u20132008 in Stockholm, Sweden, before public HPV vaccination","volume":"50","author":"J Du","year":"2011","journal-title":"Acta Oncol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1034\/j.1600-0412.2003.00263.x","article-title":"Adenocarcinoma of the uterine cervix: the presence of human papillomavirus and the method of detection","volume":"82","author":"S Andersson","year":"2003","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cdp.2004.11.003","article-title":"The relative distribution of oncogenic types of human papillomavirus in benign, pre-malignant and malignant cervical biopsies. A study with human papillomavirus deoxyribonucleic acid sequence analysis","volume":"29","author":"S Andersson","year":"2005","journal-title":"Cancer Detect Prev"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0959-8049(00)00376-2","article-title":"The role of human papillomavirus in cervical adenocarcinoma carcinogenesis","volume":"37","author":"S Andersson","year":"2001","journal-title":"Eur J Cancer"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/j.1048-891X.2004.014527.x","article-title":"HPV-DNA, vascular space invasion, and their impact on the clinical outcome in early-stage cervical carcinomas","volume":"14","author":"M Graflund","year":"2004","journal-title":"Int J Gynecol Cancer"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3892\/ol.2013.1350","article-title":"Results of cytology and high-risk human papillomavirus testing in females with cervical adenocarcinoma in situ","volume":"6","author":"S Andersson","year":"2013","journal-title":"Oncol Lett"},{"key":"ref29","unstructured":"Institut Catala d&apos;Oncologia. Human papillomavirus and related cancers in Sweden. Summary Report 2015. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.hpvcentre.net\/summaryreport.php\" xlink:type=\"simple\">http:\/\/www.hpvcentre.net\/summaryreport.php<\/ext-link>."},{"key":"ref30","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00432-006-0162-0","article-title":"Comprehensive analysis of 130 multicentric intraepithelial female lower genital tract lesions by HPV typing and p16 expression profile","volume":"133","author":"M Hampl","year":"2007","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000078559","article-title":"The most common chromosome aberration detected by high-resolution comparative genomic hybridization in vulvar intraepithelial neoplasia is not seen in vulvar squamous cell carcinoma","volume":"106","author":"T Bryndorf","year":"2004","journal-title":"Cytogenet Genome Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1097\/PAS.0b013e3180686d10","article-title":"Human papillomavirus (HPV) profiles of vulvar lesions: possible implications for the classification of vulvar squamous cell carcinoma precursors and for the efficacy of prophylactic HPV vaccination","volume":"31","author":"P Skapa","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1097\/IGC.0b013e31826a0471","article-title":"Human papillomavirus (HPV) and HPV 16-variant distribution in vulvar squamous cell carcinoma in Sweden","volume":"22","author":"GL Larsson","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ygyno.2009.12.031","article-title":"Presence of human papillomavirus (HPV) in vulvar squamous cell carcinoma (VSCC) and sentinel node","volume":"117","author":"G Lindell","year":"2010","journal-title":"Gynecol Oncol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1002\/ijc.23446","article-title":"Risk factors for invasive squamous cell carcinoma of the vulva and vagina\u2014population-based case-control study in Denmark","volume":"122","author":"BS Madsen","year":"2008","journal-title":"Int J Cancer"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1097\/01.AOG.0000245786.86267.80","article-title":"Effect of human papillomavirus vaccines on vulvar, vaginal, and anal intraepithelial lesions and vulvar cancer","volume":"108","author":"M Hampl","year":"2006","journal-title":"Obstet Gynecol"},{"key":"ref37","first-page":"30","article-title":"The presence of HPV 16, 18 and p53 immunohistochemical staining in tumor tissue of Israeli Jewish women with cervical and vulvar neoplasia","volume":"21","author":"J Menczer","year":"2000","journal-title":"Eur J Gynaecol Oncol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/modpathol.3801010","article-title":"Distribution of human papillomavirus genotypes in invasive squamous carcinoma of the vulva","volume":"21","author":"BC Sutton","year":"2008","journal-title":"Mod Pathol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/sj.bjc.6600112","article-title":"Genetic aberrations detected by comparative genomic hybridisation in vulvar cancers","volume":"86","author":"DG Allen","year":"2002","journal-title":"Br J Cancer"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1097\/01.pas.0000213291.96401.48","article-title":"The distribution of low and high-risk HPV types in vulvar and vaginal intraepithelial neoplasia (VIN and VaIN)","volume":"30","author":"M Srodon","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/01.MP.0000081051.55284.2A","article-title":"Low-grade vulvar and vaginal intraepithelial neoplasia: correlation of histologic features with human papillomavirus DNA detection and MIB-1 immunostaining","volume":"16","author":"S Logani","year":"2003","journal-title":"Mod Pathol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.ygyno.2013.02.004","article-title":"Prognostic impact of human papilloma virus (HPV) genotyping and HPV-16 subtyping in vaginal carcinoma","volume":"129","author":"GL Larsson","year":"2013","journal-title":"Gynecol Oncol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/modpathol.2008.91","article-title":"HPV DNA detection and genotyping in 21 cases of primary invasive squamous cell carcinoma of the vagina","volume":"21","author":"M Ferreira","year":"2008","journal-title":"Mod Pathol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/sti.2003.008318","article-title":"The value of anal cytology and human papillomavirus typing in the detection of anal intraepithelial neoplasia: a review of cases from an anoscopy clinic","volume":"81","author":"PA Fox","year":"2005","journal-title":"Sex Transm Infect"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/cncr.20365","article-title":"Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer","volume":"101","author":"JR Daling","year":"2004","journal-title":"Cancer"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00384-005-0777-7","article-title":"HPV in anal squamous cell carcinoma and anal intraepithelial neoplasia (AIN). Impact of HPV analysis of anal lesions on diagnosis and prognosis","volume":"21","author":"AD Varnai","year":"2006","journal-title":"Int J Colorectal Dis"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/BF02234299","article-title":"Detection and typing of human papillomavirus in anal epidermoid carcinomas: sequence variation in the E7 gene of human papillomavirus Type 16","volume":"44","author":"EG Youk","year":"2001","journal-title":"Dis Colon Rectum"},{"key":"ref48","first-page":"4473","article-title":"Human papillomavirus (HPV), DNA aberrations and cell cycle progression in anal squamous cell carcinoma patients","volume":"27","author":"N Laytragoon-Lewin","year":"2007","journal-title":"Anticancer Res"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1468-3083.2011.04069.x","article-title":"Penile intraepithelial neoplasia: histopathological evaluation, HPV typing, clinical presentation and treatment","volume":"26","author":"A Wikstr\u00f6m","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1464-410X.2010.09770.x","article-title":"Human papillomavirus prevalence, distribution and correlation to histopathological parameters in a large Swedish cohort of men with penile carcinoma","volume":"108","author":"P Kirrander","year":"2011","journal-title":"BJU Int"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1200\/JCO.2007.12.3182","article-title":"Human papillomavirus-16 is the predominant type etiologically involved in penile squamous cell carcinoma","volume":"25","author":"DA Heideman","year":"2007","journal-title":"J Clin Oncol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1365-2613.2008.00636.x","article-title":"Histological characteristics of human papilloma-virus-positive and -negative invasive and in situ squamous cell tumours of the penis","volume":"90","author":"D Krustrup","year":"2009","journal-title":"Int J Exp Pathol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1002\/ijc.22177","article-title":"Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer","volume":"119","author":"L Hammarstedt","year":"2006","journal-title":"Int J Cancer"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejca.2014.10.016","article-title":"Incidence of human papillomavirus positive tonsillar and base of tongue carcinoma: a stabilisation of an epidemic of viral induced carcinoma?","volume":"51","author":"A N\u00e4sman","year":"2015","journal-title":"Eur J Cancer"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1002\/ijc.24994","article-title":"The role of human papillomavirus in the increased incidence of base of tongue cancer","volume":"126","author":"P Attner","year":"2010","journal-title":"Int J Cancer"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/ijc.20490","article-title":"Human papillomavirus is more common in base of tongue than in mobile tongue cancer and is a favorable prognostic factor in base of tongue cancer patients","volume":"112","author":"L Dahlgren","year":"2004","journal-title":"Int J Cancer"},{"key":"ref57","first-page":"153","article-title":"Intense CD44 expression is a negative prognostic factor in tonsillar and base of tongue cancer","volume":"32","author":"D Lindquist","year":"2012","journal-title":"Anticancer Res"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/ijc.24339","article-title":"Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma?","volume":"125","author":"A N\u00e4sman","year":"2009","journal-title":"Int J Cancer"},{"key":"ref59","article-title":"Cost per patient in primary care: results from a pilot study","year":"2003"},{"key":"ref60","article-title":"General guidelines for economic evaluations from the Pharmaceutical Benefits Board (LFNAR 2003:2)","year":"2003"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2307\/3349801","article-title":"Cost-of-illness methodology: a guide to current practices and procedures","volume":"60","author":"TA Hodgson","year":"1982","journal-title":"Milbank Mem Fund Q Health Soc"},{"key":"ref62","unstructured":"Swedish Official Statistics. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.scb.se\" xlink:type=\"simple\">www.scb.se<\/ext-link>."},{"key":"ref63","article-title":"Methods for the economic evalutaion of health care programmes","author":"M Drummond","year":"2005"},{"key":"ref64","first-page":"141","article-title":"Human papillomavirus in oropharyngeal cancer: The changing face of a disease","volume":"1866","author":"J Mallen-St Clair","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"J Ferlay","year":"2010","journal-title":"Int J Cancer"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1093\/infdis\/jiw359","article-title":"Quadrivalent human papillomavirus (HPV) vaccine induces HPV-specific antibodies in the oral cavity: Results from the Mid-Adult Male Vaccine Trial","volume":"214","author":"LA Pinto","year":"2016","journal-title":"J Infect Dis"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1473-3099(14)71073-4","article-title":"Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis","volume":"15","author":"M Drolet","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1001\/jama.2014.95","article-title":"Association of varying number of doses of quadrivalent human papillomavirus vaccine with incidence of condyloma","volume":"311","author":"E Herweijer","year":"2014","journal-title":"JAMA"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1002\/ijc.30035","article-title":"Quadrivalent HPV vaccine effectiveness against high-grade cervical lesions by age at vaccination: A population-based study","volume":"138","author":"E Herweijer","year":"2016","journal-title":"Int J Cancer"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"h2016","DOI":"10.1136\/bmj.h2016","article-title":"Direct benefit of vaccinating boys along with girls against oncogenic human papillomavirus: bayesian evidence synthesis","volume":"350","author":"JA Bogaards","year":"2015","journal-title":"BMJ"},{"key":"ref71","unstructured":"Statens beredning f\u00f6r medicinsk utv\u00e4rdering, SBU. Alert report 2008\u20131. Allm\u00e4n barnvaccination mot HPV 16 och 18 i syfte att f\u00f6rebygga livmoderhalscancer. Stockholm: SBU Alert; 2008. Swedish."},{"key":"ref72","article-title":"Framework agreement\u2014Appendix 6: Price appendix. Project number 5813","year":"2014"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00019053-199813010-00001","article-title":"How to calculate indirect costs in economic evaluations","volume":"13","author":"B Liljas","year":"1998","journal-title":"Pharmacoeconomics"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0167-6296(94)00044-5","article-title":"The friction cost method for measuring indirect costs of disease","volume":"14","author":"MA Koopmanschap","year":"1995","journal-title":"J Health Econ"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10198-006-0003-8","article-title":"Cost of breast cancer in Sweden in 2002","volume":"8","author":"M Lidgren","year":"2007","journal-title":"Eur J Health Econ"},{"key":"ref76","first-page":"87","article-title":"Cost of depression in Europe","volume":"9","author":"P Sobocki","year":"2006","journal-title":"J Ment Health Policy Econ"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1136\/jnnp.69.6.792","article-title":"Brain tumours in Sweden 1996: care and costs","volume":"69","author":"P Blomqvist","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2165\/00019053-199813050-00012","article-title":"The economic cost of multiple sclerosis in Sweden in 1994","volume":"13","author":"F Henriksson","year":"1998","journal-title":"Pharmacoeconomics"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1071\/SH07043","article-title":"A cost-effectiveness analysis of adding a human papillomavirus vaccine to the Australian National Cervical Cancer Screening Program","volume":"4","author":"S Kulasingam","year":"2007","journal-title":"Sex Health"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/jama.290.6.781","article-title":"Potential health and economic impact of adding a human papillomavirus vaccine to screening programs","volume":"290","author":"SL Kulasingam","year":"2003","journal-title":"JAMA"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"e406","DOI":"10.1016\/S2214-109X(14)70237-2","article-title":"Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study","volume":"2","author":"M Jit","year":"2014","journal-title":"Lancet Glob Health"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0200554","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,7,9]],"date-time":"2018-07-09T00:00:00Z","timestamp":1531094400000}}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0179520","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T00:16:06Z","timestamp":1719274566000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0179520"}},"subtitle":[],"editor":[{"given":"Margaret","family":"McLaughlin-Drubin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,6,26]]},"references-count":81,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,6,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0179520","relation":{"correction":[{"id-type":"doi","id":"10.1371\/journal.pone.0200554","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,26]]}}}